MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$25,951K
EPS
-$1.54
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Annual
123
Page 1
Income Statement
2024-12-31
Research and development
13,006
Impairment of long-lived assets
2,705
General and administrative
15,460
Total operating expenses
31,171
Loss from operations
-31,171
Other expense, net
-265
Interest income
1,733
Gain on warrant liability
3,713
Net loss
-25,990
Unrealized gain (loss) on marketable debt securities
39
Comprehensive loss
-25,951
Basic EPS
-1.54
Diluted EPS
-1.54
Basic Average Shares
16,827,038
Diluted Average Shares
16,827,038
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS).
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$25,951K
Unrealized gain (loss) on
marketable debt securities
$39K
Net loss
-$25,990K
Gain on warrant
liability
$3,713K
Interest income
$1,733K
Loss from operations
-$31,171K
Other expense, net
-$265K
Total operating
expenses
$31,171K
General and
administrative
$15,460K
Research and development
$13,006K
Impairment of long-lived
assets
$2,705K
Buy us a coffee
Unity Biotechnology, Inc. (UBX)
Unity Biotechnology, Inc. (UBX)